Amlodipine to protect kidneys in diabetes
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests whether the blood pressure medicine amlodipine can help protect the kidneys in people with diabetes who are stable and have normal kidney function. It may reduce the risk of kidney damage from certain medical procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have diabetes.
- Your most recent kidney blood test (creatinine) is below 1.2 mg/dL.
- You do not have chronic kidney disease.
- You do not have high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if drinking beetroot juice can help protect your kidneys from damage caused by the dye used during heart procedures. It is for people hospitalized with a certain type of heart attack who are at moderate to high risk of kidney problems.
This trial tests whether a simple inorganic nitrate pill can protect your kidneys from damage caused by contrast dye used in heart catheterization or CT scans. It is for people whose kidneys are already somewhat weak, making them at higher risk for this type of injury.
This study is testing whether a class of diabetes medicines called SGLT2 inhibitors (specifically empagliflozin or dapagliflozin) can prevent kidney injury after heart procedures that use contrast dye.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
This Phase 2 study tests whether adding NAD can improve kidney health in people with diabetes-related kidney disease. It is designed for people with certain urine lab results showing kidney stress, while keeping blood sugar and safety limits within range.
This study tests whether a low dose of aspirin can protect the kidneys in people with early diabetic kidney disease. It aims to see if aspirin slows down kidney damage without causing serious side effects.
Hear when a new Contrast-induced Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.